[Inhibition of monoamine oxidase by bacteriostatically active nitrofuran derivatives].
D000313:Adrenal Medulla / Q000187:drug effects; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D003864:Depression, Chemical; D005664:Furazolidone / Q000009:adverse effects / Q000494:pharmacology*; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D008297:Male; D008995:Monoamine Oxidase / Q000378:metabolism*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009206:Myocardium / Q000378:metabolism; D009582:Nitrofurantoin / Q000494:pharmacology*; D009583:Nitrofurazone / Q000494:pharmacology*; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D013566:Sympathomimetics / Q000627:therapeutic use; D014439:Tyramine / Q000494:pharmacology
D008996:Monoamine Oxidase Inhibitors; D013566:Sympathomimetics; D012701:Serotonin; D005664:Furazolidone; D009582:Nitrofurantoin; D008995:Monoamine Oxidase; D009638:Norepinephrine; D009583:Nitrofurazone; D014439:Tyramine
Hemmung der Monoaminoxydase durch bakteriostatisch wirksame Nitrofuran-Derivate.